Literature DB >> 23802045

Atrial fibrillation in obstructive sleep apnea.

Sandeep K Goyal1, Abhishek Sharma.   

Abstract

Atrial fibrillation (AF) is a common arrhythmia with rising incidence. Obstructive sleep apnea (OSA) is prevalent among patients with AF. This observation has prompted significant research in understanding the relationship between OSA and AF. Multiple studies support a role of OSA in the initiation and progression of AF. This association has been independent of obesity, body mass index and hypertension. Instability of autonomic tone and wide swings in intrathoracic pressure are seen in OSA. These have been mechanistically linked to initiation of AF in OSA patients by lowering atrial effective refractory period, promoting pulmonary vein discharges and atrial dilation. OSA not only promotes initiation of AF but also makes management of AF difficult. Drug therapy and electrical cardioversion for AF are less successful in presence of OSA. There has been higher rate of early and overall recurrence after catheter ablation of AF in patients with OSA. Treatment of OSA with continuous positive airway pressure has been shown to improve control of AF. However, additional studies are needed to establish a stronger relationship between OSA treatment and success of AF therapies. There should be heightened suspicion of OSA in patients with AF. There is a need for guidelines to screen for OSA as a part of AF management.

Entities:  

Keywords:  Ablation; Anti-arrhythmic medications; Atrial fibrillation; Cardioversion; Obstructive sleep apnea

Year:  2013        PMID: 23802045      PMCID: PMC3691496          DOI: 10.4330/wjc.v5.i6.157

Source DB:  PubMed          Journal:  World J Cardiol


  70 in total

1.  Douglas P. Zipes Lecture. Neural mechanisms of atrial fibrillation.

Authors:  Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2006-08-10       Impact factor: 6.343

2.  Continuous positive airway pressure therapy reduces oxidative stress markers and blood pressure in sleep apnea-hypopnea syndrome patients.

Authors:  Mora Murri; Regina García-Delgado; José Alcázar-Ramírez; Luis Fernández de Rota; Ana Fernández-Ramos; Fernando Cardona; Francisco J Tinahones
Journal:  Biol Trace Elem Res       Date:  2011-02-01       Impact factor: 3.738

3.  Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.

Authors:  Maria Matiello; Mercé Nadal; David Tamborero; Antonio Berruezo; Josep Montserrat; Cristina Embid; Jose Rios; Julián Villacastín; Josep Brugada; Lluís Mont
Journal:  Europace       Date:  2010-05-20       Impact factor: 5.214

4.  Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

Authors:  Lars Frost; Lone Juul Hune; Peter Vestergaard
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

5.  Effect of CPAP on oxidative stress and circulating progenitor cell levels in sleep patients with apnea-hypopnea syndrome.

Authors:  Mora Murri; Regina García-Delgado; José Alcázar-Ramírez; Ana Fernández-Ramos; Juan Alcaide; Fernando Cardona; Francisco J Tinahones
Journal:  Respir Care       Date:  2011-05-20       Impact factor: 2.258

Review 6.  Epidemiology of atrial fibrillation: a current perspective.

Authors:  Lin Y Chen; Win-Kuang Shen
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

7.  Triggering of nocturnal arrhythmias by sleep-disordered breathing events.

Authors:  Ken Monahan; Amy Storfer-Isser; Reena Mehra; Eyal Shahar; Murray Mittleman; Jeff Rottman; Naresh Punjabi; Mark Sanders; Stuart F Quan; Helaine Resnick; Susan Redline
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

8.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

9.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

10.  Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation.

Authors:  Ri-Bo Tang; Jian-Zeng Dong; Xing-Peng Liu; Jun-Ping Kang; Shao-Fang Ding; Li Wang; De-Yong Long; Rong-Hui Yu; Xiao-Hui Liu; Shuang Liu; Chang-Sheng Ma
Journal:  Europace       Date:  2008-11-12       Impact factor: 5.214

View more
  15 in total

Review 1.  The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation.

Authors:  Lien Desteghe; Jeroen M L Hendriks; R Doug McEvoy; Ching Li Chai-Coetzer; Paul Dendale; Prashanthan Sanders; Hein Heidbuchel; Dominik Linz
Journal:  Clin Res Cardiol       Date:  2018-04-12       Impact factor: 5.460

Review 2.  The effect of sleep disordered breathing on the outcome of stroke and transient ischemic attack: a systematic review.

Authors:  Johannes Birkbak; Alice J Clark; Naja Hulvej Rod
Journal:  J Clin Sleep Med       Date:  2014-01-15       Impact factor: 4.062

Review 3.  [Medicinal treatment of atrial fibrillation in special situations].

Authors:  Dietrich Pfeiffer; Daniel Jurisch; Jens-Gerrit Kluge; Andreas Hagendorff; Norbert Klein
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-02-18

Review 4.  OSA and Cardiac Arrhythmogenesis: Mechanistic Insights.

Authors:  Anna M May; David R Van Wagoner; Reena Mehra
Journal:  Chest       Date:  2016-09-29       Impact factor: 9.410

Review 5.  Diabetes, sleep apnea, obesity and cardiovascular disease: Why not address them together?

Authors:  Salim R Surani
Journal:  World J Diabetes       Date:  2014-06-15

6.  Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach.

Authors:  Lavinia-Lucia Matei; Calin Siliste; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2021-03

7.  Severity of obstructive sleep apnea influences the effect of genotype on response to anti-arrhythmic drug therapy for atrial fibrillation.

Authors:  Sandeep K Goyal; Li Wang; Raghu Upender; Dawood Darbar; Ken Monahan
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

Review 8.  Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients.

Authors:  Karan R Chadda; Ibrahim T Fazmin; Shiraz Ahmad; Haseeb Valli; Charlotte E Edling; Christopher L-H Huang; Kamalan Jeevaratnam
Journal:  Sleep       Date:  2018-09-01       Impact factor: 5.849

9.  Obstructive Sleep Apnoea and Atrial Fibrillation.

Authors:  Ling Zhang; Yuemei Hou; Sunny S Po
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-03-15

10.  Connexins and Atrial Fibrillation in Obstructive Sleep Apnea.

Authors:  Abdelnaby Khalyfa; David Gozal
Journal:  Curr Sleep Med Rep       Date:  2018-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.